| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |